nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—kidney cancer	0.815	1	CbGaD
Gallamine Triethiodide—Skin disorder—Sorafenib—kidney cancer	0.000298	0.00161	CcSEcCtD
Gallamine Triethiodide—Headache—Temsirolimus—kidney cancer	0.000298	0.00161	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Capecitabine—kidney cancer	0.000296	0.0016	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000294	0.0016	CcSEcCtD
Gallamine Triethiodide—Fatigue—Erlotinib—kidney cancer	0.000294	0.00159	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Vinblastine—kidney cancer	0.000292	0.00158	CcSEcCtD
Gallamine Triethiodide—Pain—Erlotinib—kidney cancer	0.000292	0.00158	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Everolimus—kidney cancer	0.000291	0.00158	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Sunitinib—kidney cancer	0.000289	0.00157	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Sunitinib—kidney cancer	0.000287	0.00155	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Doxorubicin—kidney cancer	0.000286	0.00155	CcSEcCtD
Gallamine Triethiodide—Vomiting—Pazopanib—kidney cancer	0.000285	0.00154	CcSEcCtD
Gallamine Triethiodide—Anaemia—Vincristine—kidney cancer	0.000283	0.00153	CcSEcCtD
Gallamine Triethiodide—Rash—Pazopanib—kidney cancer	0.000282	0.00153	CcSEcCtD
Gallamine Triethiodide—Nausea—Temsirolimus—kidney cancer	0.000282	0.00153	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Pazopanib—kidney cancer	0.000282	0.00153	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Paclitaxel—kidney cancer	0.000281	0.00152	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Vinblastine—kidney cancer	0.00028	0.00152	CcSEcCtD
Gallamine Triethiodide—Headache—Pazopanib—kidney cancer	0.00028	0.00152	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Paclitaxel—kidney cancer	0.00028	0.00152	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00028	0.00151	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Everolimus—kidney cancer	0.000279	0.00151	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Everolimus—kidney cancer	0.000279	0.00151	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Paclitaxel—kidney cancer	0.000279	0.00151	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Paclitaxel—kidney cancer	0.000278	0.00151	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Capecitabine—kidney cancer	0.000274	0.00149	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Vincristine—kidney cancer	0.000274	0.00148	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000274	0.00148	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Capecitabine—kidney cancer	0.000272	0.00147	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Erlotinib—kidney cancer	0.00027	0.00146	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Erlotinib—kidney cancer	0.00027	0.00146	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000269	0.00146	CcSEcCtD
Gallamine Triethiodide—Anaemia—Gemcitabine—kidney cancer	0.000268	0.00145	CcSEcCtD
Gallamine Triethiodide—Nausea—Pazopanib—kidney cancer	0.000266	0.00144	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Doxorubicin—kidney cancer	0.000266	0.00144	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Sunitinib—kidney cancer	0.000265	0.00144	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000265	0.00144	CcSEcCtD
Gallamine Triethiodide—Fatigue—Sorafenib—kidney cancer	0.000265	0.00143	CcSEcCtD
Gallamine Triethiodide—Pain—Sorafenib—kidney cancer	0.000262	0.00142	CcSEcCtD
Gallamine Triethiodide—Malaise—Gemcitabine—kidney cancer	0.000262	0.00142	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Vinblastine—kidney cancer	0.000261	0.00142	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Paclitaxel—kidney cancer	0.000261	0.00141	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Everolimus—kidney cancer	0.00026	0.00141	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Gemcitabine—kidney cancer	0.00026	0.00141	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Paclitaxel—kidney cancer	0.000259	0.0014	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000255	0.00138	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000255	0.00138	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vinblastine—kidney cancer	0.000255	0.00138	CcSEcCtD
Gallamine Triethiodide—Fatigue—Sunitinib—kidney cancer	0.000255	0.00138	CcSEcCtD
Gallamine Triethiodide—Asthenia—Everolimus—kidney cancer	0.000254	0.00137	CcSEcCtD
Gallamine Triethiodide—Cough—Gemcitabine—kidney cancer	0.000253	0.00137	CcSEcCtD
Gallamine Triethiodide—Pain—Sunitinib—kidney cancer	0.000252	0.00137	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Doxorubicin—kidney cancer	0.00025	0.00136	CcSEcCtD
Gallamine Triethiodide—Pruritus—Everolimus—kidney cancer	0.00025	0.00136	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Gemcitabine—kidney cancer	0.000247	0.00134	CcSEcCtD
Gallamine Triethiodide—Chest pain—Gemcitabine—kidney cancer	0.000247	0.00134	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000245	0.00133	CcSEcCtD
Gallamine Triethiodide—Asthenia—Erlotinib—kidney cancer	0.000245	0.00133	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Vincristine—kidney cancer	0.000244	0.00132	CcSEcCtD
Gallamine Triethiodide—Urticaria—Sorafenib—kidney cancer	0.000244	0.00132	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vinblastine—kidney cancer	0.000243	0.00132	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Sorafenib—kidney cancer	0.000243	0.00131	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Sorafenib—kidney cancer	0.000243	0.00131	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Everolimus—kidney cancer	0.000242	0.00131	CcSEcCtD
Gallamine Triethiodide—Pruritus—Erlotinib—kidney cancer	0.000241	0.00131	CcSEcCtD
Gallamine Triethiodide—Fatigue—Dactinomycin—kidney cancer	0.000241	0.00131	CcSEcCtD
Gallamine Triethiodide—Pain—Dactinomycin—kidney cancer	0.000239	0.0013	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Paclitaxel—kidney cancer	0.000238	0.00129	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Sunitinib—kidney cancer	0.000233	0.00126	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Sunitinib—kidney cancer	0.000233	0.00126	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Erlotinib—kidney cancer	0.000233	0.00126	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000232	0.00126	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Dactinomycin—kidney cancer	0.00023	0.00125	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Capecitabine—kidney cancer	0.00023	0.00125	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Gemcitabine—kidney cancer	0.00023	0.00125	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Capecitabine—kidney cancer	0.00023	0.00124	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Capecitabine—kidney cancer	0.000229	0.00124	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Capecitabine—kidney cancer	0.000228	0.00124	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000227	0.00123	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Sorafenib—kidney cancer	0.000226	0.00122	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vinblastine—kidney cancer	0.000226	0.00122	CcSEcCtD
Gallamine Triethiodide—Vomiting—Everolimus—kidney cancer	0.000225	0.00122	CcSEcCtD
Gallamine Triethiodide—Anaemia—Paclitaxel—kidney cancer	0.000225	0.00122	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Vincristine—kidney cancer	0.000224	0.00121	CcSEcCtD
Gallamine Triethiodide—Rash—Everolimus—kidney cancer	0.000223	0.00121	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Everolimus—kidney cancer	0.000223	0.00121	CcSEcCtD
Gallamine Triethiodide—Headache—Vinblastine—kidney cancer	0.000222	0.0012	CcSEcCtD
Gallamine Triethiodide—Angioedema—Paclitaxel—kidney cancer	0.000222	0.0012	CcSEcCtD
Gallamine Triethiodide—Headache—Everolimus—kidney cancer	0.000221	0.0012	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Dactinomycin—kidney cancer	0.000221	0.0012	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Dactinomycin—kidney cancer	0.000221	0.0012	CcSEcCtD
Gallamine Triethiodide—Asthenia—Sorafenib—kidney cancer	0.00022	0.00119	CcSEcCtD
Gallamine Triethiodide—Malaise—Paclitaxel—kidney cancer	0.000219	0.00119	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Paclitaxel—kidney cancer	0.000218	0.00118	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Sunitinib—kidney cancer	0.000217	0.00118	CcSEcCtD
Gallamine Triethiodide—Pruritus—Sorafenib—kidney cancer	0.000217	0.00118	CcSEcCtD
Gallamine Triethiodide—Vomiting—Erlotinib—kidney cancer	0.000217	0.00117	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000216	0.00117	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000216	0.00117	CcSEcCtD
Gallamine Triethiodide—Fatigue—Vincristine—kidney cancer	0.000215	0.00117	CcSEcCtD
Gallamine Triethiodide—Rash—Erlotinib—kidney cancer	0.000215	0.00117	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Erlotinib—kidney cancer	0.000215	0.00116	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Capecitabine—kidney cancer	0.000214	0.00116	CcSEcCtD
Gallamine Triethiodide—Headache—Erlotinib—kidney cancer	0.000214	0.00116	CcSEcCtD
Gallamine Triethiodide—Pain—Vincristine—kidney cancer	0.000214	0.00116	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000213	0.00116	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Gemcitabine—kidney cancer	0.000213	0.00115	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Capecitabine—kidney cancer	0.000213	0.00115	CcSEcCtD
Gallamine Triethiodide—Cough—Paclitaxel—kidney cancer	0.000212	0.00115	CcSEcCtD
Gallamine Triethiodide—Asthenia—Sunitinib—kidney cancer	0.000212	0.00115	CcSEcCtD
Gallamine Triethiodide—Nausea—Vinblastine—kidney cancer	0.000211	0.00114	CcSEcCtD
Gallamine Triethiodide—Nausea—Everolimus—kidney cancer	0.00021	0.00114	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Sorafenib—kidney cancer	0.00021	0.00114	CcSEcCtD
Gallamine Triethiodide—Pruritus—Sunitinib—kidney cancer	0.000209	0.00113	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Paclitaxel—kidney cancer	0.000207	0.00112	CcSEcCtD
Gallamine Triethiodide—Chest pain—Paclitaxel—kidney cancer	0.000207	0.00112	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Dactinomycin—kidney cancer	0.000206	0.00112	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000205	0.00111	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000204	0.00111	CcSEcCtD
Gallamine Triethiodide—Fatigue—Gemcitabine—kidney cancer	0.000204	0.00111	CcSEcCtD
Gallamine Triethiodide—Pain—Gemcitabine—kidney cancer	0.000203	0.0011	CcSEcCtD
Gallamine Triethiodide—Nausea—Erlotinib—kidney cancer	0.000203	0.0011	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Sunitinib—kidney cancer	0.000202	0.00109	CcSEcCtD
Gallamine Triethiodide—Asthenia—Dactinomycin—kidney cancer	0.000201	0.00109	CcSEcCtD
Gallamine Triethiodide—Confusional state—Paclitaxel—kidney cancer	0.0002	0.00108	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Vincristine—kidney cancer	0.000197	0.00107	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Vincristine—kidney cancer	0.000197	0.00107	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Capecitabine—kidney cancer	0.000195	0.00106	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Gemcitabine—kidney cancer	0.000195	0.00106	CcSEcCtD
Gallamine Triethiodide—Vomiting—Sorafenib—kidney cancer	0.000195	0.00106	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—kidney cancer	0.000195	0.00106	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000194	0.00105	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Paclitaxel—kidney cancer	0.000194	0.00105	CcSEcCtD
Gallamine Triethiodide—Rash—Sorafenib—kidney cancer	0.000193	0.00105	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Sorafenib—kidney cancer	0.000193	0.00105	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Paclitaxel—kidney cancer	0.000193	0.00104	CcSEcCtD
Gallamine Triethiodide—Headache—Sorafenib—kidney cancer	0.000192	0.00104	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Dactinomycin—kidney cancer	0.000191	0.00104	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—kidney cancer	0.000191	0.00103	CcSEcCtD
Gallamine Triethiodide—Vomiting—Sunitinib—kidney cancer	0.000188	0.00102	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Gemcitabine—kidney cancer	0.000187	0.00101	CcSEcCtD
Gallamine Triethiodide—Rash—Sunitinib—kidney cancer	0.000186	0.00101	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Sunitinib—kidney cancer	0.000186	0.00101	CcSEcCtD
Gallamine Triethiodide—Headache—Sunitinib—kidney cancer	0.000185	0.001	CcSEcCtD
Gallamine Triethiodide—Anaemia—Capecitabine—kidney cancer	0.000184	0.000999	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Vincristine—kidney cancer	0.000184	0.000997	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—kidney cancer	0.000183	0.00099	CcSEcCtD
Gallamine Triethiodide—Nausea—Sorafenib—kidney cancer	0.000182	0.000987	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000181	0.000979	CcSEcCtD
Gallamine Triethiodide—Malaise—Capecitabine—kidney cancer	0.00018	0.000974	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vincristine—kidney cancer	0.000179	0.000971	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Capecitabine—kidney cancer	0.000179	0.000967	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Paclitaxel—kidney cancer	0.000178	0.000965	CcSEcCtD
Gallamine Triethiodide—Vomiting—Dactinomycin—kidney cancer	0.000178	0.000963	CcSEcCtD
Gallamine Triethiodide—Rash—Dactinomycin—kidney cancer	0.000176	0.000955	CcSEcCtD
Gallamine Triethiodide—Nausea—Sunitinib—kidney cancer	0.000175	0.00095	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—kidney cancer	0.000175	0.000949	CcSEcCtD
Gallamine Triethiodide—Cough—Capecitabine—kidney cancer	0.000174	0.000943	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000171	0.000928	CcSEcCtD
Gallamine Triethiodide—Fatigue—Paclitaxel—kidney cancer	0.000171	0.000927	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vincristine—kidney cancer	0.000171	0.000926	CcSEcCtD
Gallamine Triethiodide—Asthenia—Gemcitabine—kidney cancer	0.00017	0.000921	CcSEcCtD
Gallamine Triethiodide—Chest pain—Capecitabine—kidney cancer	0.00017	0.00092	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Capecitabine—kidney cancer	0.00017	0.00092	CcSEcCtD
Gallamine Triethiodide—Pain—Paclitaxel—kidney cancer	0.00017	0.000919	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000169	0.000914	CcSEcCtD
Gallamine Triethiodide—Pruritus—Gemcitabine—kidney cancer	0.000168	0.000908	CcSEcCtD
Gallamine Triethiodide—Nausea—Dactinomycin—kidney cancer	0.000166	0.0009	CcSEcCtD
Gallamine Triethiodide—Confusional state—Capecitabine—kidney cancer	0.000164	0.000889	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Paclitaxel—kidney cancer	0.000163	0.000886	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Gemcitabine—kidney cancer	0.000162	0.000878	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Capecitabine—kidney cancer	0.000159	0.000864	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Capecitabine—kidney cancer	0.000159	0.000861	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vincristine—kidney cancer	0.000159	0.00086	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Capecitabine—kidney cancer	0.000158	0.000857	CcSEcCtD
Gallamine Triethiodide—Urticaria—Paclitaxel—kidney cancer	0.000158	0.000854	CcSEcCtD
Gallamine Triethiodide—Rash—Vincristine—kidney cancer	0.000157	0.000853	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vincristine—kidney cancer	0.000157	0.000852	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Paclitaxel—kidney cancer	0.000157	0.00085	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Paclitaxel—kidney cancer	0.000157	0.00085	CcSEcCtD
Gallamine Triethiodide—Headache—Vincristine—kidney cancer	0.000156	0.000848	CcSEcCtD
Gallamine Triethiodide—Vomiting—Gemcitabine—kidney cancer	0.000151	0.000816	CcSEcCtD
Gallamine Triethiodide—Rash—Gemcitabine—kidney cancer	0.000149	0.000809	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Gemcitabine—kidney cancer	0.000149	0.000809	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—kidney cancer	0.000148	0.000804	CcSEcCtD
Gallamine Triethiodide—Headache—Gemcitabine—kidney cancer	0.000148	0.000804	CcSEcCtD
Gallamine Triethiodide—Nausea—Vincristine—kidney cancer	0.000148	0.000804	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000148	0.000804	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—kidney cancer	0.000148	0.000802	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—kidney cancer	0.000148	0.0008	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000147	0.000796	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Capecitabine—kidney cancer	0.000146	0.000792	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Paclitaxel—kidney cancer	0.000146	0.000792	CcSEcCtD
Gallamine Triethiodide—Asthenia—Paclitaxel—kidney cancer	0.000142	0.000771	CcSEcCtD
Gallamine Triethiodide—Nausea—Gemcitabine—kidney cancer	0.000141	0.000762	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000141	0.000761	CcSEcCtD
Gallamine Triethiodide—Fatigue—Capecitabine—kidney cancer	0.00014	0.00076	CcSEcCtD
Gallamine Triethiodide—Pruritus—Paclitaxel—kidney cancer	0.00014	0.00076	CcSEcCtD
Gallamine Triethiodide—Pain—Capecitabine—kidney cancer	0.000139	0.000754	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—kidney cancer	0.000138	0.000748	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—kidney cancer	0.000137	0.000743	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Paclitaxel—kidney cancer	0.000136	0.000735	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Capecitabine—kidney cancer	0.000134	0.000727	CcSEcCtD
Gallamine Triethiodide—Urticaria—Capecitabine—kidney cancer	0.000129	0.000701	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Capecitabine—kidney cancer	0.000129	0.000697	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Capecitabine—kidney cancer	0.000129	0.000697	CcSEcCtD
Gallamine Triethiodide—Vomiting—Paclitaxel—kidney cancer	0.000126	0.000683	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—kidney cancer	0.000126	0.000682	CcSEcCtD
Gallamine Triethiodide—Rash—Paclitaxel—kidney cancer	0.000125	0.000678	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Paclitaxel—kidney cancer	0.000125	0.000677	CcSEcCtD
Gallamine Triethiodide—Headache—Paclitaxel—kidney cancer	0.000124	0.000673	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Capecitabine—kidney cancer	0.00012	0.00065	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—kidney cancer	0.000119	0.000644	CcSEcCtD
Gallamine Triethiodide—Nausea—Paclitaxel—kidney cancer	0.000118	0.000638	CcSEcCtD
Gallamine Triethiodide—Asthenia—Capecitabine—kidney cancer	0.000117	0.000633	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—kidney cancer	0.000116	0.000628	CcSEcCtD
Gallamine Triethiodide—Pruritus—Capecitabine—kidney cancer	0.000115	0.000624	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—kidney cancer	0.000115	0.000624	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—kidney cancer	0.000112	0.000608	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Capecitabine—kidney cancer	0.000111	0.000603	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—kidney cancer	0.000109	0.000593	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—kidney cancer	0.000109	0.000593	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000109	0.000589	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—kidney cancer	0.000106	0.000573	CcSEcCtD
Gallamine Triethiodide—Vomiting—Capecitabine—kidney cancer	0.000103	0.000561	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000103	0.000557	CcSEcCtD
Gallamine Triethiodide—Rash—Capecitabine—kidney cancer	0.000103	0.000556	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Capecitabine—kidney cancer	0.000103	0.000556	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—kidney cancer	0.000102	0.000555	CcSEcCtD
Gallamine Triethiodide—Headache—Capecitabine—kidney cancer	0.000102	0.000552	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—kidney cancer	0.000102	0.000552	CcSEcCtD
Gallamine Triethiodide—Nausea—Capecitabine—kidney cancer	9.67e-05	0.000524	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.56e-05	0.000518	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—kidney cancer	9.42e-05	0.00051	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.06e-05	0.000491	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—kidney cancer	9.04e-05	0.00049	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—kidney cancer	8.97e-05	0.000486	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—kidney cancer	8.65e-05	0.000468	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—kidney cancer	8.33e-05	0.000452	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—kidney cancer	8.29e-05	0.000449	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—kidney cancer	8.29e-05	0.000449	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—kidney cancer	7.73e-05	0.000419	CcSEcCtD
Gallamine Triethiodide—Asthenia—Doxorubicin—kidney cancer	7.53e-05	0.000408	CcSEcCtD
Gallamine Triethiodide—Pruritus—Doxorubicin—kidney cancer	7.42e-05	0.000402	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—kidney cancer	7.18e-05	0.000389	CcSEcCtD
Gallamine Triethiodide—Vomiting—Doxorubicin—kidney cancer	6.67e-05	0.000361	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—kidney cancer	6.61e-05	0.000358	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—kidney cancer	6.61e-05	0.000358	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—kidney cancer	6.57e-05	0.000356	CcSEcCtD
Gallamine Triethiodide—Nausea—Doxorubicin—kidney cancer	6.23e-05	0.000338	CcSEcCtD
